Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06218706
NA

LIFU for Treatment for Refractory Opioid Use Disorder

Sponsor: Ali Rezai

View on ClinicalTrials.gov

Summary

This is a randomized, double-blind, sham-controlled, partial crossover study investigating LIFU targeting the NAc and VC for participants with severe, treatment refractory OUD.

Official title: A Randomized, Sham-Controlled Trial Investigating Low Intensity Focused Ultrasound as a Novel Treatment for Refractory Opioid Use Disorder

Key Details

Gender

All

Age Range

22 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

34

Start Date

2024-05-09

Completion Date

2028-03-01

Last Updated

2026-02-17

Healthy Volunteers

No

Interventions

DEVICE

Low Intensity Focussed Ultrasound

The major objective of this study is to further test safety, tolerability, and feasibility of LIFU in this population as well as investigate the impact of LIFU on opioid and other substance use. The primary endpoint is 90 days (Post-LIFU Week 12) following Active/Sham LIFU. After the primary endpoint is reached, the blind will be broken and the group who received Sham LIFU will cross-over and receive Active LIFU

Locations (1)

WVU Rockefeller Neuroscience Institute

Morgantown, West Virginia, United States